Track Inari Medical, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Inari Medical, Inc. NARI · Stock Open Inari Medical, Inc. in new tab

79.97 USD
EPS
-0.99
P/B
5.74
ROE
-13.28
Beta
1.00
Target Price
64.93 USD
Loading chart...
Key Metrics
EPS-0.99
Book Value7.29
Price to Book5.74
Debt/Equity7.82
% Insiders9.018%
Growth
Revenue Growth0.23%
Estimates
Forward P/E190.00
Forward EPS0.22
Target Mean Price64.93

DCF valuation

Model fair value for Inari Medical, Inc. (NARI)
Result
Sign in to run the valuation for NARI.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
mean target 64.93 USD (low 47.00, high 86.00)
Low 47.00
Mean 64.93
High 86.00
Price 79.97
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Inari Medical, Inc. Logo Inari Medical, Inc. Analysis (NARI)

United States Health Care Official Website Stock

Is Inari Medical, Inc. a good investment? Inari Medical, Inc. (NARI) is currently trading at 79.97 USD. Market analysts have a consensus price target of 64.93 USD. This suggests the asset is currently trading above analyst expectations.

Investor FAQ

Does Inari Medical, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Inari Medical, Inc.?

Inari Medical, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Exchange Ticker
NMS (United States) NARI
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion